65,437 trials
Depressive Disorder, Major
Primary: Change From Treatment Baseline in Montgomery Asberg Depression Rating Scale (MADRS) Total Score at Treatment Week 6 in Participants Who Were Non-Responders During…
Amputation
Primary: Prosthetic Comfort and Utility Questionnaire (Version 1) — 25.52; 29.33 score on a scale
Autoimmune Pulmonary Alveolar Proteinosis
Primary: Time to Rescue WLL — 18; 30 Months — p=0.0078
Preventive Health Services · Health Promotion
Primary: Receipt of Preventive Care Services: Anticipatory Guidance Topics Received by Parent Report at Well Visits — 73.9; 63.3 score on a scale
Hereditary Angioedema
Primary: Number of Participants With Treatment Emergent Adverse Events (TEAEs) Including Serious TEAEs and Adverse Events of Special Interest (AESI) — 11; 1; 8; 1 Participants
Pulmonary Embolism
Primary: Percentage of Patient Visits Where the Provider Adopted the Pulmonary Embolism Risk Kalculator (PERK) Tool — 39.11; 20.66 Percentage of Patient Visits
Obesity · Glucose Homeostasis · Postmenopausal Symptoms
Primary: Change in Body Mass Index — -0.2; -0.5 Kg/m^2
Gender Dysphoria · Opioid Use · Pain, Postoperative
Primary: Comparison of Post Operative Pain Scores — 3.0; 3.6 score on a scale
Malaria
Primary: Malaria Status — 18; 16 Participants
Extensive Stage Lung Small Cell Carcinoma · Recurrent Lung Small Cell Carcinoma
Primary: Progression-free Survival (PFS) — 5.5; 4.9 months — p=0.17
Marginal Zone Lymphoma · Waldenstrom Macroglobulinemia · Non Follicular Indolent Non-Hodgkin Lymphoma
Primary: Overall Response Rate (ORR) as Assessed by Revised Response Criteria for Non- Hodgkin's Lymphoma (Lugano Classification) and Consensus-Based 6th International Workshop…
Neurotrophic Keratitis
Primary: Corneal Epithelial Healing — 5; 28 Participants
Postoperative Gastrointestinal Dysfunction
Primary: Time From End of the Surgery to Resolution of Upper and Lower Gastrointestinal (GI) Function Postsurgery as Assessed by the Investigator — 1.89; 2.76; 2.59; 2.62 days…
PTSD · Sleep Problems
Primary: Sleep Efficiency — 88.13; 89.95; 89.31; 89.20 Percentage of Sleep
Virus Diseases · RNA Virus Infections · Respiratory Tract Diseases
Primary: Number of Occurrences of Protocol-Defined Influenza-Like Illness (ILI) Due to Any Laboratory-Confirmed Influenza Strains — 118; 130 Number of cases